Literature DB >> 19353224

Influence of direct admission to Comprehensive Stroke Centers on the outcome of acute stroke patients treated with intravenous thrombolysis.

Natalia Pérez de la Ossa1, Mónica Millán, Juan F Arenillas, Josep Sánchez-Ojanguren, Ernest Palomeras, Laura Dorado, Cristina Guerrero, Antoni Dávalos.   

Abstract

Acute stroke patients can be transferred directly to a Comprehensive Stroke Center (CSC), where acute stroke expertise is provided 24 h a day, seven days a week, and thrombolytic treatment is administered; or they may initially receive attention at an unspecialized community hospital with secondary transfer to the CSC. Our aim is to analyze the influence of previous attention at unspecialized community hospitals on the outcome of ischemic stroke patients treated with thrombolysis. We studied 153 consecutive ischemic stroke patients treated with t-PA over a 30-month period. The primary outcome variable was functional independence at 90 days (Rankin scale, mRS </= 2). Secondary outcomes were neurologic improvement at 24 h, rate of arterial recanalization and symptomatic intracerebral hemorrhage. Forty-five patients (29.5%) received initial attention at community hospitals with secondary transfer to the CSC. Median time from onset to t-PA administration was shorter in patients with direct access to the CSC (135 vs. 165 min; p < 0.001) and stroke severity was higher (NIHSS 12 vs. 9; p = 0.017). Patients who received initial attention at the CSC had a higher frequency of neurologic improvement (59.3% vs. 37.2%; p = 0.014) and a lower rate of symptomatic hemorrhage (4.7% vs. 14%; p = 0.04). Compared to initial attention at an unspecialized hospital, direct admission to the CSC was associated with an odds ratio of 2.48 (95% CI, 1.04-5.88; p = 0.039) for good outcome after adjustment for stroke severity at baseline and other potential confounders. Direct access to a CSC is associated with shorter onset-to-treatment time and better outcome for ischemic stroke patients treated with thrombolysis in comparison with initial attention at an unspecialized hospital with secondary transfer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19353224     DOI: 10.1007/s00415-009-5113-7

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  19 in total

1.  European Stroke Initiative Recommendations for Stroke Management-update 2003.

Authors:  Tom Skyhoj Olsen; Peter Langhorne; Hans Christoph Diener; Michael Hennerici; Jose Ferro; Johani Sivenius; Nils Gunnar Wahlgren; Philip Bath
Journal:  Cerebrovasc Dis       Date:  2003       Impact factor: 2.762

2.  Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.

Authors:  Nils Wahlgren; Niaz Ahmed; Antoni Dávalos; Gary A Ford; Martin Grond; Werner Hacke; Michael G Hennerici; Markku Kaste; Sonja Kuelkens; Vincent Larrue; Kennedy R Lees; Risto O Roine; Lauri Soinne; Danilo Toni; Geert Vanhooren
Journal:  Lancet       Date:  2007-01-27       Impact factor: 79.321

3.  Benefits of a prehospital stroke code system. Feasibility and efficacy in the first year of clinical practice in Barcelona, Spain.

Authors:  Robert Belvís; Dolores Cocho; Joan Martí-Fàbregas; Javier Pagonabarraga; Aitziber Aleu; María Dolores García-Bargo; Jordi Pons; Eva Coma; Fernando García-Alfranca; Xavier Jiménez-Fàbrega; Josep Lluis Martí-Vilalta
Journal:  Cerebrovasc Dis       Date:  2004-12-17       Impact factor: 2.762

4.  Prehospital and emergency department delays after acute stroke: the Genentech Stroke Presentation Survey.

Authors:  D L Morris; W Rosamond; K Madden; C Schultz; S Hamilton
Journal:  Stroke       Date:  2000-11       Impact factor: 7.914

Review 5.  Intracranial hemorrhage associated with revascularization therapies.

Authors:  Pooja Khatri; Lawrence R Wechsler; Joseph P Broderick
Journal:  Stroke       Date:  2007-01-18       Impact factor: 7.914

6.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

Authors:  Werner Hacke; Markku Kaste; Erich Bluhmki; Miroslav Brozman; Antoni Dávalos; Donata Guidetti; Vincent Larrue; Kennedy R Lees; Zakaria Medeghri; Thomas Machnig; Dietmar Schneider; Rüdiger von Kummer; Nils Wahlgren; Danilo Toni
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

7.  [Stroke code impact on the efficacy of thrombolytic treatment].

Authors:  José Alvarez-Sabín; Carlos A Molina; Sonia Abilleira; Joan Montaner; Fernando García Alfranca; Xavier Jiménez Fabrega; Juan Arenillas; Rafael Huertas; Marc Ribó; Manuel Quintana; Agustin Codina
Journal:  Med Clin (Barc)       Date:  2003-01-25       Impact factor: 1.725

8.  Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

Authors:  Werner Hacke; Geoffrey Donnan; Cesare Fieschi; Markku Kaste; Rüdiger von Kummer; Joseph P Broderick; Thomas Brott; Michael Frankel; James C Grotta; E Clarke Haley; Thomas Kwiatkowski; Steven R Levine; Chris Lewandowski; Mei Lu; Patrick Lyden; John R Marler; Suresh Patel; Barbara C Tilley; Gregory Albers; Erich Bluhmki; Manfred Wilhelm; Scott Hamilton
Journal:  Lancet       Date:  2004-03-06       Impact factor: 79.321

9.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

10.  Delay in neurological attention and stroke outcome. Cerebrovascular Diseases Study Group of the Spanish Society of Neurology.

Authors:  A Dávalos; J Castillo; E Martinez-Vila
Journal:  Stroke       Date:  1995-12       Impact factor: 7.914

View more
  6 in total

1.  From the stroke unit to the stroke competence center: corresponding beneficial clinical and financial effects.

Authors:  A Chatzikonstantinou; A Förster; M G Hennerici; H Bäzner
Journal:  J Neurol       Date:  2011-04-06       Impact factor: 4.849

2.  Interhospital transfer on intravenous thrombolysis in patients with acute ischemic stroke in three chinese municipal stroke centers.

Authors:  Yunlong Ding; Zhanyi Ji; Li Ma; Tingting Zhai; Zhiqun Gu; Jiali Niu; Yan Liu
Journal:  J Thromb Thrombolysis       Date:  2019-11       Impact factor: 2.300

Review 3.  The chain of care enabling tPA treatment in acute ischemic stroke: a comprehensive review of organisational models.

Authors:  Maarten M H Lahr; Gert-Jan Luijckx; Patrick C A J Vroomen; Durk-Jouke van der Zee; Erik Buskens
Journal:  J Neurol       Date:  2012-08-23       Impact factor: 4.849

Review 4.  Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association.

Authors:  Daniel T Lackland; Edward J Roccella; Anne F Deutsch; Myriam Fornage; Mary G George; George Howard; Brett M Kissela; Steven J Kittner; Judith H Lichtman; Lynda D Lisabeth; Lee H Schwamm; Eric E Smith; Amytis Towfighi
Journal:  Stroke       Date:  2013-12-05       Impact factor: 7.914

5.  Outcomes of thrombolytic therapy in acute ischemic stroke: mothership, drip-and-ship, and ship-and-drip paradigms.

Authors:  Naruchorn Kijpaisalratana; Aurauma Chutinet; Wasan Akarathanawat; Pakkawan Vongvasinkul; Nijasri C Suwanwela
Journal:  BMC Neurol       Date:  2020-02-03       Impact factor: 2.474

6.  Predictors of discharge to home after thrombolytic treatment in right hemisphere infarct patients.

Authors:  E-I Ruuskanen; M Laihosalo; Je Kettunen; H Losoi; L Nurmi; A-M Koivisto; P Dastidar; J Ollikainen; M Jehkonen
Journal:  J Cent Nerv Syst Dis       Date:  2010-12-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.